PlainRecalls
FDA Drug Moderate Class II Terminated

Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68

Reported: February 24, 2021 Initiated: January 22, 2021 #D-0264-2021

Product Description

Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68

Reason for Recall

CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.

Details

Recalling Firm
Ascend Laboratories LLC
Units Affected
23,436 200 mL bottles
Distribution
Nationwide in the USA
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68. Recalled by Ascend Laboratories LLC. Units affected: 23,436 200 mL bottles.
Why was this product recalled?
CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 24, 2021. Severity: Moderate. Recall number: D-0264-2021.